News

Follow:
13684 Articles

NIO: FQ4’23 May Be A Smashing Success (NYSE:NIO)

We previously covered NIO Inc. (NYSE:NYSE:NIO) in September 2023, discussing its mixed FQ2'23 earnings call, attributed to the underwhelming top/

By News

Pfizer: The Bears Have Won This Round (NYSE:PFE)

We previously covered Pfizer (NYSE:NYSE:PFE) in September 2023, discussing its pessimistic performance as the decelerating COVID-19 portfolio and underperforming bolt-on

By News

My 2 Latest Acquisitions For The Dividend Income Accelerator Portfolio

Investment Thesis In one of my recent articles, I conducted a comprehensive risk-analysis on the current composition of The Dividend

By News

Embracing Dividend Opportunities In 2024

A Conversation with Jeff Schulze, John Baldi and Tatiana Eades Yields rose stiffly in 2023, driven by the Federal Reserve’s

By News

IPO Update: Telomir Pharmaceuticals Proposes IPO Terms (Pending:TELO)

A Quick Take On Telomir Pharmaceuticals Telomir Pharmaceuticals (TELO) has filed proposed terms to raise $7 million from the sale

By News

AltaGas Stock: Not Cheap But I Like The Growth Projections (ATGFF)

Introduction AltaGas (TSX:ALA:CA) (OTCPK:ATGFF) is a Canadian energy infrastructure company focusing on its utilities and midstream divisions. In the midstream

By News

Meta Gets A Big Boost As X Falters (NASDAQ:META)

After the initial hype around Meta’s (NASDAQ:META) Threads in the initial phase, we have seen slower addition of new users.

By News

Bank Of America: Grab The 6% Yield Preferreds (NYSE:BAC)

Brian Moynihan Bank of America (NYSE:BAC) is a stock I’ve had some great experiences with lately. I bought it heavily

By News